IMATIB (MITINAB) TABLET – TREATMENT FOR MULTIPLE CANCER
Tyrosine kinase inhibitors are a class of drugs that includes Mitinab Tablet. It is used to treat gastrointestinal stromal tumors as well as two types of blood cancer: chronic myeloid leukemia and acute lymphocytic leukemia.
To obtain the best benefit, the Mitinab tablet should be taken with food at the same time each day. As long as your doctor recommends it, you should keep taking it. Depending on your needs and how you respond to treatment, the length of treatment varies. It can have potentially dangerous negative effects if taken improperly or in excess.
USES OF IMATIB (MITINAB) TABLET
- Blood cancer (Chronic myeloid leukemia)
- Blood cancer (Acute lymphocytic leukemia)
- Gastrointestinal stromal tumor
WORKS OF IMATIB (MITINAB) TABLET
A cancer-prevention drug is called Mitinab Tablet. Bcr-Abl tyrosine kinase is a protein enzyme that is in charge of the aberrant proliferation of cancer cells. In bar-all positive cells, this medication suppresses proliferation and causes apoptosis (planned cell death) (cancer cells). This is how the progression of cancer is slowed or stopped.
SIDE EFFECTS OF IMATIB (MITINAB) TABLET
- Edema (swelling)
- Muscle cramp
- Musculoskeletal (bone, muscle, or joint) pain
- Abdominal pain
WARNING & PRECAUTIONS
Mitinab Tablet adverse effects may impair your ability to operate a motor vehicle.
It is dangerous to use Mitinab tablets when pregnant because there is clear evidence that doing so puts the unborn child at risk. However, if the advantages outweigh the possible risks, a doctor might very rarely recommend it in specific life-threatening circumstances. Please speak with your physician.
Fedelty Health Care is an Imatib third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.